Chitosan and its derivatives for ocular delivery formulations: Recent advances and developments

A Zamboulis, S Nanaki, G Michailidou, I Koumentakou… - Polymers, 2020 - mdpi.com
Chitosan (CS) is a hemi-synthetic cationic linear polysaccharide produced by the
deacetylation of chitin. CS is non-toxic, highly biocompatible, and biodegradable, and it has …

Breaking barriers in eye treatment: Polymeric nano-based drug-delivery system for anterior segment diseases and glaucoma

KY Wu, S Ashkar, S Jain, M Marchand, SD Tran - Polymers, 2023 - mdpi.com
The eye has anatomical structures that function as robust static and dynamic barriers,
limiting the penetration, residence time, and bioavailability of medications administered …

Betaxolol‐loaded niosomes integrated within pH‐sensitive in situ forming gel for management of glaucoma

A Allam, M Elsabahy, M El Badry, NE Eleraky - International Journal of …, 2021 - Elsevier
Blindness and impaired vision are considered as the most troublesome health conditions
leading to significant socioeconomic strains. The current study focuses on development of …

Intranasal zolmitriptan-loaded bilosomes with extended nasal mucociliary transit time for direct nose to brain delivery

MM El Taweel, MH Aboul-Einien, MA Kassem… - Pharmaceutics, 2021 - mdpi.com
This study aimed at delivering intranasal zolmitriptan directly to the brain through
preparation of bilosomes incorporated into a mucoadhesive in situ gel with extended nasal …

Emerging potential of niosomes in ocular delivery

A Verma, A Tiwari, S Saraf, PK Panda… - Expert opinion on …, 2021 - Taylor & Francis
Introduction Niosomes have recently grabbed attention as one of the best tools for various
site-specific drug delivery systems, including ophthalmic drug delivery. Surfactants …

Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: Ex-vivo permeation and in-vivo pharmacodynamic study

AE Eldeeb, S Salah, M Ghorab - Journal of Drug Delivery Science and …, 2019 - Elsevier
Glaucoma, a chronic disease of elevated intraocular pressure, is considered as the first
leading cause of blindness. Brimonidine tartrate (BRT), a hydrophilic drug with poor ocular …

Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019

CT Supuran, ASA Altamimi, F Carta - Expert opinion on therapeutic …, 2019 - Taylor & Francis
Introduction: Glaucoma affects more than 70 million people worldwide. One of the major
therapeutic options for its management is based on the inhibition of the metalloenzyme …

Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo …

AA Nemr, GM El-Mahrouk, HA Badie - Drug delivery, 2022 - Taylor & Francis
Agomelatine (AGO) is a dual-functional drug. It uses as an antidepressant when orally
administrated and antiglaucomic when topically applied to the eye. This study aimed to …

Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo …

A Emad Eldeeb, S Salah, M Ghorab - Drug delivery, 2019 - Taylor & Francis
Brimonidine tartrate (BRT) is a hydrophilic α2 adrenergic agonist used for the treatment of
glaucoma. Glaucoma is an ocular disease affecting the anterior segment of the eye requiring …

Corneal targeted Sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies

NF Younes, SA Abdel-Halim, AI Elassasy - International journal of …, 2018 - Elsevier
Sertaconazole nitrate (STZ) is a poorly soluble antifungal drug commonly used for treating
fungal skin infections. Introducing it as a new treatment option for the management of fungal …